Clinical Trials Logo

Postpartum Haemorrhage clinical trials

View clinical trials related to Postpartum Haemorrhage.

Filter by:

NCT ID: NCT01116050 Completed - Clinical trials for Postpartum Haemorrhage

Intrarectal Misoprostol in Postpartum Haemorrhage

HEMOSTOP
Start date: January 2004
Phase: Phase 3
Study type: Interventional

Postpartum haemorrhage (PPH) remains the major cause of maternal mortality in France. The most efficient treatment of severe PPH is sulprostone which is associated with cardiac complications. The objective of this study was to assess the efficacy and the safety of intrarectal misoprostol for curative postpartum haemorrhage treatment. We conducted a multicenter double blind randomized placebo control trial between June 2004 and December 2007, among consenting women with postpartum haemorrhage and failure to oxytocin treatment. Our main criteria of judgement was quantification of blood loss and the use of sulprostone between the two groups using either misoprostol intrarectal tablets (5X200mg ) or placebo in similar opaque introducer.

NCT ID: NCT01044082 Completed - Clinical trials for Postpartum Haemorrhage

Prevention of Post-partum Haemorrhage

TRACOR
Start date: January 2010
Phase: N/A
Study type: Interventional

The primary purpose of the trial is to evaluate whether the management of placental delivery with controlled cord traction (CCT) reduces the incidence of postpartum haemorrhage, compared with management waiting for clinical signs of spontaneous placental separation, in women with vaginal delivery receiving prophylactic oxytocin for the management of the third stage of labour. The hypothesis is that CCT, by reducing the length of the third stage of labour, facilitates early postpartum uterine contraction and local haemostasis and decreases post partum blood loss.

NCT ID: NCT00872469 Completed - Clinical trials for Postpartum Haemorrhage

World Maternal Antifibrinolytic Trial

WOMAN
Start date: May 2009
Phase: Phase 3
Study type: Interventional

The WOMAN trial is a large pragmatic randomised double-blind, placebo controlled trial to quantify the effects of the early administration of tranexamic acid on death, hysterectomy and other relevant outcomes. 20,000 adult women, after delivery who have clinically diagnosed postpartum haemorrhage, are eligible if the responsible doctor is for any reason substantially uncertain whether or not to use an antifibrinolytic agent. Additionally, TWO nested studies will be conducted in a subset of women trial participants. The first nested study (ETAC) aims to evaluate the effect of tranexamic acid (TXA) on markers of coagulation in 400 women randomised to the WOMAN trial. The second nested study (ETAPLAT) aims to evaluate the haemostatic effect and antithrombotic effect of TXA in 128 women randomised to the WOMAN trial.

NCT ID: NCT00499005 Completed - Clinical trials for Postpartum Haemorrhage

Carbetocin Versus Syntometrine for the Third Stage of Labour

Start date: November 2006
Phase: Phase 4
Study type: Interventional

Intramuscular carbetocin is as effective as intramuscular syntometrine for the prevention of postpartum haemorrhage